Closing the Diagnostic Gap in
Women's Health.
Florya is a clinical screening platform that bridges the diagnostic gap in women's health by correlating symptoms with evidence-based protocols for PCOS, Endometriosis, Hormonal Health, and Metabolic conditions.
Why Florya Exists
Women with conditions like PCOS and Endometriosis face an average diagnostic delay of 7-10 years. Nearly half receive an initial misdiagnosis. Hormonal overlaps mask root causes, and markers that are "technically normal" but functionally sub-optimal are routinely dismissed.
Florya was built to change this — to transform fragmented symptoms and static lab results into structured, physician-ready clinical evidence.
Our Principles
Clinical Rigor
Every screening protocol is grounded in peer-reviewed medical research and validated clinical frameworks.
Patient First
We believe every woman deserves access to comprehensive diagnostic tools, not just a snapshot of lab results.
Tracking Over Time
Health is not a single data point. We build continuous narratives that evolve with your journey.
Evidence-Based Protocols
Every Florya assessment is built on internationally recognized clinical frameworks.
Rotterdam Protocol
International standard for PCOS classification into Types A-D based on hyperandrogenism, ovulatory dysfunction, and polycystic morphology.
ASRM Guidelines
American Society for Reproductive Medicine criteria for endometriosis staging and inflammatory risk scoring.
POI & HA Screening
Premature Ovarian Insufficiency and Hypothalamic Amenorrhea detection through biomarker correlation.
HOMA-IR Assessment
Homeostatic Model Assessment for insulin resistance — a critical marker in PCOS and metabolic screening.
Your symptoms deserve clinical answers.
Completely free. Takes under 10 minutes. Your results are private, secure, and physician-ready.